SEC Filings for Novartis AG (NVS)

$ 85.69   -0.10 (-0.12%) Volume: 1.8m 4:00 PM EDT 20-Oct-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934710/16/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934509/23/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934609/01/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934808/20/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals708/19/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934408/17/2020
3Initial statement of beneficial ownership of securities108/14/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934307/21/2020
4Statement of changes in beneficial ownership of securities107/16/2020
3Initial statement of beneficial ownership of securities207/13/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934507/02/2020
4Statement of changes in beneficial ownership of securities107/02/2020
3Initial statement of beneficial ownership of securities206/25/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934506/25/2020
4Statement of changes in beneficial ownership of securities106/22/2020
<<
First
<
Prev
123456789101112131415